The Future of 3D Printing in Medicine and Dentistry

2018 Speakers

Tom Barrett

Tom Barrett, President DiSanto Technology, Inc. ( DTI )

Tom Barrett is the President of DiSanto Technology, Inc ( DTI ), one of the businesses in the Arcam Group, now part of GE Additive. The Arcam Group provides cost-efficient Additive Manufacturing solutions for production of metal components primarily for the aerospace and medical industries. Arcam offers Electron Beam Melting technology equipment through Arcam AB in Sweden, powder metals through AP&C in Canada and medical device implant contract manufacturing through DTI.

Mr. Barrett has been in the medical device industry for over 25 years, working for both OEMs and contract manufacturers. Mr. Barrett has spent over 20 years in orthopedics, with 13 years at Stryker and 7 years in contract manufacturing, including leadership positions in Symmetry Medical and Tecomet. He holds a BS in Mechanical Engineering from Union College and a Master in Business Administration from the Harvard Business School.

Session: Panel I - 3D-Printed Medical Implants

Jenny Chen

Hui Jenny Chen, M.D., CEO/Founder, 3DHeals

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS, a company focusing on curating healthcare 3D printing ecosystem. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Session: Panel V - The Future of 3D Printing in Medical Markets

Kenneth Church

Dr. Kenneth Church, CEO, nScrypt Inc.

Dr. Church is the Chairman and CEO of nScrypt, Inc. nScrypt is a capital equipment company that sells micro-dispensing platforms for 3D applications. nScrypt is a spin off from Sciperio, Inc. which Dr. Church founded in 1996. Sciperio Inc. is a research company for advanced innovation. His work with nScrypt and Sciperio has been in a wide range of technical areas to include 3D printing, electronics, antennas, tissue engineering, water and sensors. He and his team have been pioneers in 3D printed biological structures for tissue engineering. The ability to combine biotic and abiotic materials in a 3D structure will impact a wide range of life science applications.

Session: Panel VI - 3D Printing Biomedical Materials

Lyman Connor

Lyman Connor, Founder and Chief Technical Officer, Handsmith

Originally from Indiana, PA, Lyman Connor studied Science and Engineering at Indiana University of Pennsylvania and UNC Pemberton before enlisting in the United States Navy for six years. Post-Navy, he worked in a myriad of manufacturing industries and power production. In addition to his current role as Global Design Lead of Turbine Controls at General Electric, he founded the NPO Handsmith, Inc. to provide low-cost prosthetics and other enabling devices to the economically disadvantaged. In his spare time, Lyman is an avid cyclist and loves exploring museums and new applications for emerging technology in his microfactory.

Session: Panel II - 3D-printed Prosthetics

Scott DeFelice

Scott DeFelice , President and CEO, Oxford Performance Materials

Prior to founding OPM in 2000, CEO and Chairman Scott DeFelice was co-founder and Vice President of Marketing at Oxford Polymers, a compounder of engineered thermoplastics, where he led the firm’s innovation, strategy, and business development activities.

Mr. DeFelice has grown OPM to become a recognized leader in 3D printing and high performance additive manufacturing (HPAM™). A proven entrepreneur in the fields of cutting edge materials and additive manufacturing, DeFelice’s company has developed a range of advanced materials technology focused on a high performance polymer, poly-ether-ketone-ketone (PEKK), and delivers enterprise level, functional end-use products to the biomedical, aerospace and industrial markets as the first company to successfully apply additive manufacturing solutions to PEKK.

In addition to OPM, Mr. DeFelice serves on the Sustainability Committee of America Makes - the National Additive Manufacturing Innovation Institute.

Session: Panel I - 3D-Printed Medical Implants

Dr. Matthew Di Prima

Dr. Matthew Di Prima, Materials Scientist, CDRH / OSEL, U.S. Food and Drug Administration

Dr. Matthew Di Prima received bachelors in Materials Science and Engineering from Rice University (2005) and his doctorate in Materials Science and Engineering from the Georgia Institute of Technology (2009). For the last 7 years, he has been working as materials scientist at the Center for Devices and Radiological Health in the US Food and Drug Administration. His areas of research are investigating how the additive manufacturing process can alter material properties, the interplay between corrosion and durability testing, and explant analysis. Along with his research duties, he is the co-Chair of the Additive Manufacturing Working Group which is spearheading efforts across the Agency to address how this technology affects medical devices and other regulate medical products. These efforts include guidance and standards development, device review harmonization, and performing regulatory science with the intent to foster innovative and high quality products while maintaining they have the same safety and effectiveness that Americans have come to expect.

Session: Panel V - The Future of 3D Printing in Medical Markets

Lee Dockstader

Lee Dockstader, Director of Vertical Market Development, HP Inc.

Lee Dockstader is the Director of Vertical Market Development of HP’s 3D printing business. He is engaging the global product development process to grow additive manufacturing across verticals including Aerospace, Automotive, Medical, Dental, Life Sciences, Consumer and Retail. Emphasis is on developing production applications for HP’s Multi Jet Fusion 3D printing technology.

Before HP, Lee held several positions during his 18-year career at 3D Systems including VP of Business Development, VP and General Manager of the Stereolithography Products Business Unit and VP and GM of the Asia Pacific region. Before 3D Systems, Lee worked for three years at 3D/EYE Inc, a leading-edge 3D software company as sales and distribution manager.

For 11 years he held a variety of sales and marketing positions at Hewlett-Packard. During this period, Lee spent three years as program manager for HP’s Asia mechanical engineering CAD business, based in Hong Kong. Lee attended the West Point Military Academy and received a Bachelor of Science degree in Engineering from UCLA.

Session: Keynote: HP

Scott Dunham

Scott Dunham, Vice President of Research, SmarTech Markets Publishing

Scott Dunham is Vice President of Research at SmarTech Markets Publishing, bringing with him years of research experience in the areas of advanced manufacturing and 3D printing. Scott holds a Bachelor’s degree in marketing and research from the University of Kentucky’s Gatton School of Business & Economics, and has been a featured speaker at 3D printing industry events around the world.

Session: The Future of Additive Medical: A Presentation of Market Forecasts
Session: “Additive Dental” Market Opportunities

Maria Esquela

Maria Esquela, Founder and President, Enable Alliance

Maria Esquela, is the founder and president of the Alliance for Project Based Learning Solutions, DBA the “e NABLE Alliance.” APBLS is a 501(c)(3) tax-exempt non-profit. It supports and develops resources for the e-NABLE Community, known for designing, fabricating and gifting 3D printed upper limb prosthetics. This global community of digital humanitarians using crowd sourcing and open source designs to “give the world a helping hand.” APBLS promotes e-NABLE’s model of collaborative research and innovation, and also boosts mentoring, empowerment and access to technology in outreach to underserved communities. Using the eNABLE model, device recipients in community are collaborative researchers, subject matter experts include Citizen Science and mentoring in their work, and educators supplement open source files with e NABLE STEM-based service learning projects and curriculum shared under a Creative Commons license. She has been an active e NABLE Volunteer and leader since 2014, when she and her child completed 14 Do-It-Yourself myoelectric neuroprosthetic experiments at a fully equipped Level 1 synthetic biology facility - a wetlab makerspace where citizen scientists share scientific equipment, supplies, and professional scientific mentorship. She created the first retreat and “assembly line” workshop models for the e NABLE “Hand-a-thon team building events for formaland informal educational settings, and brought the e NABLE project to Scout troops around the world as a model Messengers of Peace project. Prior to founding APBLS, she was the senior coordinator of all neuroscience residencies and fellowships at the Johns Hopkins University School of Medicine, and is a certified HL7 Clinical Document Architechture Specialist.

Session: Panel II - 3D-printed Prosthetics

Adam W. Feinberg

Adam W. Feinberg, Associate Professor, Carnegie Mellon University

Dr. Feinberg is the principal investigator of the Regenerative Biomaterials and Therapeutics Group and an Associate Professor at Carnegie Mellon University. He earned his BS in Materials Science and Engineering from Cornell University in 1999 with Co-op experience at Abiomed, Inc., working on total artificial hearts. He then earned MS and PhD degrees in Biomedical Engineering from the University of Florida, focused on engineering cell-material interactions to prevent and enhance adhesion. This was followed by postdoctoral training at Harvard University, developing new biomaterials and stem cell-based cardiac tissue engineering strategies. He joined the faculty at Carnegie Mellon in the fall of 2010 with joint appointments in Biomedical Engineering and Materials Science and Engineering. Dr. Feinberg has co-authored over 40 peer-reviewed publications and holds 16 US patents and patent applications. He has also been awarded the NSF CAREER Award, the NIH Director’s New Innovator Award, and the American Heart Association Scientist Development Grant. Current research is focused on biomimetic strategies to fabricate ECM protein-based materials from fibronectin, laminin, and collagens type I and IV to build 2D and 3D scaffolds for corneal and cardiac tissue engineering, and other applications. Further, he is working to understand the biomechanics and mechanobiology of these engineered ECM protein materials, specifically how strain modulates biological activity.

Session: Panel VI - 3D Printing Biomedical Materials

Michael W. Golway

Michael W. Golway, CEO, Advanced Solutions

American entrepreneur, engineer and inventor. In November 2000, at the age of 31, Michael acquired his first technology company, IDS Engineering. The company had 2 employees with a focused business model of workflow consulting services. Today he is President & CEO of Advanced Solutions, Inc., which is a privately held company he acquired in November 2004, and parent company to seven technology businesses, including IDS Engineering. Michael’s passion is building and acquiring great technology companies, while growing market share through innovation. He is the lead inventor for the integrated solution of BioAssemblyBot® and TSIM™, a 6‐Axis Robotic 3D Printing System for Human Tissue Structures. Michael has over two decades of experience leading multi-disciplined engineering, consulting and technology firms.

Session: Panel VI - 3D Printing Biomedical Materials

Lawrence Gasman

Lawrence Gasman, President, SmarTech Markets Publishing

Lawrence Gasman is the founder of SmarTech Markets Publishing and is acknowledged worldwide as an expert on technology forecasting. He has previously founded two other industry analyst firms and has also carried out a wide range of technology assessments in areas ranging from optical networking to advanced materials
to augmented reality.

Session: Welcome to the Conference
Session: Panel VII - Additive Medicine and Dentistry: Investment Industry and VC Perspective

Laura Gilmour

Laura Gilmour, Global Medical Business Development Manager, EOS North America

Laura Gilmour, Global Medical Business Development Manager of EOS North America, oversees more than 20 medical device OEMs and contract manufacturers using EOS technology in North America. She joined EOS in 2016 after working with the company as a customer during her 15 years as a biomedical research and development engineer.
Previously, Laura was a senior research engineer at Smith and Nephew Orthopedics where she and a team of engineers developed an advanced porous structure now used in orthopedic applications around the world. She also worked at Medtronic Spine and Biologics and Abbott Vascular where she was responsible for translating surgical needs into medical device designs. Prior to that, Laura spent two years as a pre-market reviewer for the U.S. Food and Drug Administration (FDA), reviewing and clearing more than 80 orthopedic devices. During her time at the FDA, Laura was a founding member of the organization’s Additive Manufacturing Working Group.
Laura is a member of the SME Medical Additive Manufacturing/3D Printing Working Group and the Society of Women Engineers. She holds a bachelor’s degree in bioengineering from the University of Pittsburgh and a master’s degree in biomedical engineering from the University of Tennessee Health Science Center.

Session: Panel I - 3D-Printed Medical Implants

Charles Goulding

Charles Goulding, Attorney, CPA and President, R&D Tax Savers

Charlie is an Attorney / CPA, and President of two national specialty tax firms, Energy Tax Savers and R&D Tax Savers.

Energy Tax Savers has helped 15,000 buildings obtain energy tax savings and R&D Tax Savers has helped a range of industries obtain hundreds of millions in R&D tax incentives.

Charlie is an author of over 50 published articles related to the tax aspects of 3D printing and is recognized as a top 40 3D printer master mind.

Before starting both firms 12 years ago, Charlie was previously Vice President of Dover Corporation and Managing Director of Eaton/Cooper which are two multi-billion dollar industrial companies.

He is also the Mayor of Oyster Bay Cove, Long Island.

Session: Panel VII - Additive Medicine and Dentistry: Investment Industry and VC Perspective

Fabien Guillemot

Dr. Fabien Guillemot, CE & CSO, Poietis

Fabien has an over 15 years experience in the field of regenerative medicine. He holds a PhD in Science from INSA, the National Institute of Materials and Applied Sciences, of Rennes (2000) and a habilitation to lead Research in Health and Life Sciences issued by Bordeaux Segalen University (2010). Fabien was appointed Researcher at INSERM in 2005 and was also Guest Researcher at Harvard University in 2010 in the Cell and Tissue Engineering Laboratory. He also has completed its scientific training by entrepreneurship education provided to HEC (Challenge + program) in 2012. Fabien has initiated pioneering work internationally in the field of bioprinting and published over 20 scientific articles and directed more than 50 invited lectures on this new technology.

Session: Panel VI - 3D Printing Biomedical Materials

Andrew R. Hanson

Andrew R. Hanson, Additive Manufacturing Research Engineer, Stratasys

Andrew Hanson is a Research Engineer in Stratasys’ manufacturing products group. His main research topics include metamaterial development, intelligent machine & process control, and cyber-physical system architectures for additive manufacturing technologies in the defense & space industries. Andrew is also the primary investigator for the America Makes project developing cyber-physical design and additive manufacturing of custom orthoses. Andrew studied Mechanical Engineering at the University of St. Thomas in Minnesota.

Session: Panel II - 3D-printed Prosthetics

John Hartner

John Hartner, Founder, Digital Industrialist LLC

John F. Hartner has led technology companies around the world for over 25 years in electronics, cleantech, automation and digital printing industries. John founded and leads, Digital Industrialist, an early stage venture fund that focuses on 3D Printing, especially in medical, materials and software. Previously he was COO of EnvisionTEC Inc. a leading provider of 3D printing solutions in medical, dental and bio-fabrication applications. Much of his career was spent leading Fortune 500 multi-national firms. Most recently he was President of Dover’s Digital Printing segment, grew and sold Dover’s Electronics Technology group, ran FMC Technology in Asia and he started his career at Rockwell International. For half of these years, John lived and ran businesses in Asia and Europe. He graduated from Villanova University with a Bachelors in Mechanical Engineering and he completed his MBA at the University of Chicago. John serves on the Villanova Engineer College Advisory Board, the board of Maria Mitch Science Center and is part of the Young Presidents Organization. Although John now lives between Florida and NY, he grew up in Pittsburgh where he was inspired by great industrialist like Carnegie and Rockefeller. His current work and investments in 3D printing are meant to help power the next Industrial Revolution.

Session: Panel VII - Additive Medicine and Dentistry: Investment Industry and VC Perspective

John Hornick

John Hornick, Partner, Finnegan

John has been a counselor and litigator in the Washington, D.C. office of the Finnegan IP law firm (one of the largest IP firms in the world) for over 30 years, where he has litigated close to 100 IP cases and has negotiated hundreds of settlements. John founded Finnegan’s 3D Printing Working Group and advises clients about how 3D printing may affect their businesses. John frequently speaks and writes on 3D printing and has been recognized as a thought leader in this space. He is the author of the book, 3D Printing Will Rock the World, which won a Silver Award from the Nonfiction Authors Association and has been called a “must-read” offering “rare insight into how 3D printing is redefining what can be designed and manufactured.” His articles have been published at,, in the Journal of 3D Printing & Additive Manufacturing, where he serves on the Editorial Board, and in Wired Innovation, and he was a columnist for 3D Printing World. He was the only IP attorney selected by the U.S. Comptroller General Forum on Additive Manufacturing (which is the basis of a report to Congress). John has served as a juror for the International Additive Manufacturing Award. John also educates the law enforcement community on 3D printing-related risks and benefits. John holds a certificate in Cybersecurity Oversight from Carnegie Mellon University and the National Association of Corporate Directors.

Session: Panel V - The Future of 3D Printing in Medical Markets

Rik Jacobs

Rik Jacobs, General Manager, Dental, 3D Systems

Rik Jacobs is a founder and the former CEO of NextDent B.V. The company was founded in 2012 in the Netherlands as an independent subsidiary of Vertex Global Holding to complement the dental materials portfolio of its affiliate Vertex-Dental B.V., which has a 77-year track record in developing and producing traditional denture materials and products. Within four years, NextDent became the leading developer and manufacturer of biocompatible dental 3D printing materials. In January 2017, Vertex Global Holding merged with 3D Systems, a company that provides comprehensive Additive Manufacturing products and services, including 3D printers specifically designed for dental applications, print materials, on-demand parts services and digital design tools. Upon this merger, Rik became the General Manager of the Dental business. He holds a degree in International Marketing Management from NHL University of Applied Science.

Session: Panel VIII - The Future of 3D Printing in Dental Markets

David Labiak

David Labiak, Senior Portfolio Manager, Trent Capital Management

David Labiak, President, CFO and Senior Portfolio Manager of Trent Capital Management, a Greensboro, NC-based Registered Investment Advisor providing investment management services since 1987. David is also the Chief Investment Officer for 3D Tech Plus, a private fund/LLC formed in July 2013 with the sole objective of investing in companies involved in the 3D printing industry. He is also responsible for implementing strategic planning and assumes many client-related responsibilities including portfolio reviews. Prior to joining Trent Capital, David was employed by Belk Stores Services in their audit department. David received his bachelor degree in accounting from the University of North Carolina at Charlotte, later obtaining his MBA from the Walker College of Business at Appalachian State University. In September 2000, he received his Chartered Financial Analyst designation and is a member of the CFA N.C. Society.

Session: Panel VII - Additive Medicine and Dentistry: Investment Industry and VC Perspective

Joseph Lipman

Joseph Lipman, Director of Device Development, Hospital for Special Surgery

I have over 25 years of medical research and device development experience and have worked with multiple services at HSS including Adult Hip and Knee Replacement, Foot and Ankle, Hand and Upper Extremity, Hip Preservation, Spine and Sports Medicine. In working with these services and the Biomechanics department, I’ve contributed to the development of implants for the knee, hip, elbow and spine. These implants have been licensed to several orthopaedic companies and are sold worldwide. I am an inventor of sixteen patented medical devices and have multiple publications in the medical device area. In addition, I am a registered US Patent Agent.

Session: Panel IV - End Users Hospital and Clinic Experiences and Strategies

Justin S. Marks

Justin S. Marks, Founder / CEO, Arfona

Justin Marks, CDT is the Founder and CEO of Arfona LLC, a startup specializing in digital manufacturing methods for dental prosthetics. He is also the owner of Master-Touch Dental Lab in Brooklyn, New York. An accomplished dental technician, educator and lab owner, Justin has lectured and taught courses on removable prosthodontics in more than 40 countries. He is an expert in flexible partial denture materials and applications and a pioneer in the field of digital dentures and partials. Since 2008 Justin has dedicated most of his career to applying computer aided design and 3D printing technologies to removable prosthodontics and is credited with the invention of the world’s first 3D printed Valplast partial denture. Justin graduated Summa Cum Laude from Pace University and holds a BBA in marketing and management.

Session: Panel VIII - The Future of 3D Printing in Dental Markets

Gaurav Manchanda

Gaurav Manchanda, Healthcare Solutions Manager, Formlabs

Gaurav Manchanda is healthcare solutions manager at Formlabs, the designer and manufacturer of powerful and accessible 3D printing systems. At Formlabs, Gaurav is leading the company’s healthcare initiatives in medical education and in areas such as orthotics and various surgical specialties.

Session: Panel III - 3D-Printing in Surgical Planning and Modeling

Brian R. McLaughlin

Brian R. McLaughlin, VP of Engineering, Quality & Operations, Additive Orthopaedics LLC

Session: Panel I - 3D-Printed Medical Implants

Dr. Jonathan Morris MD

Dr. Jonathan Morris MD, Physician, Mayo Clinic

Session: Panel IV - End Users Hospital and Clinic Experiences and Strategies

Dr. Roger Narayan

Dr. Roger Narayan, Professor of Biomedical Engineering UNC/NC State and America Makes Fellow

Roger Narayan is a Professor in the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University. He is an author of over two hundred publications as well as several book chapters on medical devices and medical sensors. He has edited several textbooks, handbooks, reference books, including books on medical biosensors for point of care applications as well as on materials for medical devices. Dr. Narayan has received several honors for his research activities, including the University of North Carolina Jefferson-Pilot Fellowship in Academic Medicine and the American Ceramic Society Richard M. Fulrath Award. He has been elected as Fellow of the American Ceramic Society, ASM International, AAAS, and AIMBE. He recently served as an ASME Swanson Fellow with America Makes, the national additive manufacturing institute.

Session: Additive Medical Markets: Technical and Regulatory Aspects

Kara Noack

Kara Noack, Business Development, BASF

Kara Noack leads the business development for BASF 3D Printing Solutions in NA and is located in the greater Detroit, MI area. Detroit is being developed as the NA 3DP hub for BASF, capitalizing on synergies with BASF’s Performance Materials, Ink, and Coating divisions also located in this metro area. Having a B.S. in Chemical Engineering from Michigan Technological University, she has spent most of her career in commercial roles in a variety of industries. She entered the Additive Manufacturing effort at BASF in January 2015 and has become a true believer in the potential of 3D-Printing to be disruptive in manufacturing. Her charter is to connect BASF’s material and service solutions with users across markets with an overarching message of:

  • BASF partners on open 3DP platforms to enable material choices and direct end customer engagement with BASF.
  • Affordability with volumes
  • Innovations to enable functional parts and production.
  • Solutions above and beyond materials

Session: Panel II - 3D-printed Prosthetics

Todd Pietila

Todd Pietila, Business Development Manager, Materialise

Todd is a Business Development Manager at Materialise where he specializes in delivering 3D software and 3D printing consultancy to the healthcare field. With degrees in Biomedical Engineering and Master of Business Administration, he has spent more than 8 years at Materialise focused on developing applications of 3D printing in medicine.”

Session: Panel III - 3D-Printing in Surgical Planning and Modeling

Steve Pollack

Steve Pollack, Senior Staff Research Scientist, Carbon, Inc., and Former 3DP Director OSEL, CDRH

Dr. Pollack is Research Scientist at Carbon, focused on life science applications. Prior to this he was Director of the Office of Science and Engineering Laboratories (OSEL), the applied research arm of the FDA’s Center for Devices and Radiological Health and Director of the Division of Chemistry and Materials Science within OSEL. At the FDA he was an evangelist for the acceptance of 3D printing as a viable and safe technology for medical device manufacturing. Prior to this he was Deputy Laboratory Head in the Center for Bio/Molecular Science and Engineering at the U.S. Naval Research, held research and management positions at American Hospital Supply Corporation, Allergan Pharmaceuticals and Springborn Laboratories and has held faculty positions at the University of Cincinnati in Materials Science and Engineering and at Howard University, where he was Professor of Chemistry.

Session: Panel V - The Future of 3D Printing in Medical Markets
Session: Panel VIII - The Future of 3D Printing in Dental Markets

Davide Sher

Davide Sher, Senior Analyst, 3DP Adoption Studies, SmarTech Markets Publishing

Davide Sher is Senior Analyst, 3DP Adoption Studies at SmarTech Markets Publishing and has built an extensive experience as a technology journalist and communication consultant. Davide was born in Milan, Italy and spent 12 years in the United States, where he received his BA from SUNY Stony Brook. He now lives in Milan and collaborates with several 3D printing news portals. He founded, currently the largest global directory of 3DP related companies, as well as the leading Italian 3DP news portal

Session: The Market for Bioprinting

Arif Sirinterlikci

Arif Sirinterlikci, University Professor of Industrial and Manufacturing Engineering, Director of Engineering Laboratories and Head, Department of Engineering, Robert Morris University

Arif Sirinterlikci is a University Professor of Industrial and Manufacturing Engineering at Robert Morris University. He also serves as the Head of Engineering and Director of Engineering Laboratories at Robert Morris. He holds BS and MS degrees both in Mechanical Engineering from Istanbul Technical University (Turkey) and a Ph.D. in Industrial and Systems Engineering from the Ohio State University. He is also a Certified Manufacturing Engineer (CMfgE). His experience in 3D Printing spans more than 20 years. His research and teaching activities involved Rapid Prototyping for Biomedical Product Development, 3D Printer Development, 3D Printing Materials Development, Rapid Tooling, and Rep-Rap and Hobbyist Printer Space as well as Environment, Health, and Safety (EHS) work in the area. His original and collaborative work in 3D Printing was recently recognized by the Emerald Literati Network and Rapid Prototyping Journal with a Highly Commended Paper Award in 2015.

Session: Panel II - 3D-printed Prosthetics

William (Bo) Sutch

William (Bo) Sutch, Senior Account Manager, North America Prodways

Session: Panel VIII - The Future of 3D Printing in Dental Markets

Patrick Thayer

Patrick Thayer, Bioink Officer, CELLINK LLC

Patrick Thayer is the Bioink Officer at CELLINK. Before starting at CELLINK he earned his BS from Georgia Tech in Biomedical Engineering and his PhD from Virginia Tech. At CELLINK he hopes to use his experiences in academia to develop novel tools and materials for any researcher that wants to get involved or is working in the bioprinting field.

Session: Panel VI - 3D Printing Biomedical Materials

Marc Thurner

Marc Thurner, CEO, RegenHU

Marc Thurner is CEO and founder of regenHU Ltd. Active in the advancement of biofabrication for over 15 years he is a leading contributor to the 3D bioprinting and tissue engineering scene.

Session: Panel VI - 3D Printing Biomedical Materials

Katie Weimer

Katie Weimer, VP Medical Devices, 3D Systems

As VP Medical Devices, Healthcare, 3D Systems, Katie Weimer leads the company’s Denver healthcare operations, specializing in Virtual Surgical Planning (VSP®), 3D printed medical devices and patient-specific anatomical models, surgical guides and templates. Katie joined Medical Modeling in 2008 (acquired by 3D Systems in 2014), and is passionate about enabling better healthcare through innovative technologies. Katie received her master’s degree in mechanical engineering from the University of Missouri-Kansas City, and writes and speaks frequently on her expertise in personalized surgery.

Keynote: Virtual Surgical Planning, Integrating Precision Healthcare with 3D Technologies for Better Surgical Outcomes

Robert Wesley

Robert Wesley, 3D Printing Engineer, St. Louis Children’s Hospital of BJC Healthcare

Robert graduated from Tennessee Tech University in 2013 with a BS in Biomolecular Engineering and North Carolina A&T State University in 2015 with a MS in Bioengineering. He worked in several academic research labs such as environmental health, biomolecular medicine, fuel cell, and computational biomechanics before entering the world of 3D printing. He works as a 3D Printing Engineer for St. Louis Children’s Hospital of BJC Healthcare. Under the direction of Dr. Christine Pavlak, Dr. Shafkat Anwar, Dr. Eric Eutsler, and Dr. Kamlesh Patel, Robert is responsible of the operations of the 3D printing program which involve preparation of process workflow, surgical guides, and virtual and physical models for pre-operative planning and patient education.

Keynote: Panel IV - End Users Hospital and Clinic Experiences and Strategies

Share This